ArticleFrontiers in molecular biosciences2021

Development of a Toll-Like Receptor-Based Gene Signature That Can Predict Prognosis, Tumor Microenvironment, and Chemotherapy Response for Hepatocellular Carcinoma.

Lixia Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.